* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shan Dong Kexing Bioproducts Co Days Payable Chart
SHSE:688136 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shan Dong Kexing Bioproducts Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shan Dong Kexing Bioproducts Co's Days Payable falls into.
Shan Dong Kexing Bioproducts Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shan Dong Kexing Bioproducts Co (SHSE:688136) has a Days Payable of 166.98 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. This is 27% below median its historical median of 229.25. Over the past decade, Shan Dong Kexing Bioproducts Co's Days Payable has ranged from 127.91 to 424.85. According to the industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #324 out of 701 companies in the Biotechnology industry, placing it in the top 46.2%.
Is Shan Dong Kexing Bioproducts Co's Days Payable too high?
Shan Dong Kexing Bioproducts Co's current Days Payable of 166.98 is 27% below median its 10-year median of 229.25. Over the past 10 years, this metric has ranged from a low of 127.91 to a high of 424.85. The Biotechnology industry median Days Payable is 112.84. Shan Dong Kexing Bioproducts Co's value of 166.98 is 48% above this industry median. Based on the distribution chart, Shan Dong Kexing Bioproducts Co ranks #324 out of 701 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Shan Dong Kexing Bioproducts Co has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shan Dong Kexing Bioproducts Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #324 out of 701 companies for Days Payable. This puts Shan Dong Kexing Bioproducts Co in the upper half of its industry. The industry median Days Payable is 112.84. Shan Dong Kexing Bioproducts Co's value of 166.98 is 48% above this benchmark. Historically, Shan Dong Kexing Bioproducts Co's own Days Payable has ranged from 127.91 to 424.85 over the past decade. While the company's 10-year median is 229.25 vs. the industry median of 112.84, Shan Dong Kexing Bioproducts Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shan Dong Kexing Bioproducts Co's current Days Payable of 166.98 is 48% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shan Dong Kexing Bioproducts Co's current Days Payable is 166.98, which is 27% below median its own 10-year median of 229.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shan Dong Kexing Bioproducts Co stock overvalued right now?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co (SHSE:688136) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.98, compared to a current price of ¥21.00 — trading 12.4% below its estimated fair value. The current Days Payable is 166.98, which is 27% below median its 10-year median of 229.25 and 48% above the Biotechnology industry median of 112.84. Shan Dong Kexing Bioproducts Co's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shan Dong Kexing Bioproducts Co (SHSE:688136), the current Days Payable is 166.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shan Dong Kexing Bioproducts Co (SHSE:688136) Overvalued in 2026?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co stock appears to be undervalued.
The current stock price of ¥21.00 is trading 12.4% below its estimated GF Value™ of ¥23.98.
GuruFocus considers Shan Dong Kexing Bioproducts Co to be Modestly Undervalued.
Key valuation signals for SHSE:688136:
Days Payable: 166.98 (27% below median its 10-year median of 229.25)
GF Value™: ¥23.98 vs. price of ¥21.00 (12.4% below fair value)
Industry Position: 48% above the Biotechnology median (#324 of 701)
No single metric tells the full story. See the SHSE:688136 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shan Dong Kexing Bioproducts Co Business Description
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
44GF Score
Get the complete analysis for SHSE:688136
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688136 has been successfully added to your 
